Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of cell cycle regulator proteins in non-small cell lung cancer

23 Dec 2003

Abstract excerpt

BACKGROUND/AIMS: Abnormalities of the proteins involved in cell cycle checkpoints are extremely common among almost all neoplasms. This study aimed to investigate the expression of four components of the cell cycle machinery-p21, p16, p53, and proliferating cell nuclear antigen (PCNA)-in non-small cell lung cancer (NSCLC). METHODS: The expression of p21, p16, p53, and PCNA was examined in 68 well characterised...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Cancer-related Molecular Pathways
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14693837
DOI: 10.1136/jcp.57.1.58

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of cell cycle regulator proteins in non-small cell lung cancerPMID 14693837Read ↗

Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancerSemantic proximity Read ↗

P53 and Rb Aberrations in Small Cell Lung Cancer (SCLC): From Molecular Mechanisms to Therapeutic ModulationSemantic proximity Read ↗

Tumor Suppressors and Cell-Cycle Proteins in Lung CancerSemantic proximity Read ↗

Cell cycle alterations and lung cancer.Semantic proximity Read ↗

Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.Semantic proximity Read ↗

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerSemantic proximity Read ↗

G1 control gene status is frequently altered in resectable non-small cell lung cancer.Semantic proximity Read ↗

Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).Semantic proximity Read ↗

[Deregulation of cell cycle control in lung cancer].Semantic proximity Read ↗

Prognostic significance of different biomarkers in non-small cell lung cancer.Semantic proximity Read ↗

CDK4/6 inhibition stabilizes disease in patients with p16-null non-small cell lung cancer and is synergistic with mTOR inhibitionSemantic proximity Read ↗

Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.